Login
Toggle navigation
Videos
Categories
Trending
"Factoring transforms invoices into immediate cash, offering fast payment solutions and benefits for trucking companies."
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Alex Li · Founder/CEO at Apex Capital
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:00:00
Arthur Bedrosian, CEO, Lannett Company Inc
00:10:00
Ole Kristian Sivertsen: CEO of Desert Control, Championing Climate-Smart Solutions for a Sustainable Future | Ole Kristian Sivertsen, CEO, Desert Control AS.
00:10:00
Dynasty Gold Corp’s Ivy Chong Discusses Exciting Discoveries and Future Plans at Flagship Ontario Project
00:10:00
John Inch of Gordon Haskett provides in-depth insights on market trends and investment strategies in this full interview.
00:10:00
Gary Harris on Navigating Market Cycles and Client-Centric Investment Strategies
00:10:00
Inflation's Impact on Your Investments – Insights from Jacobson & Schmitt Advisors
00:10:00
Partners with exceptional entrepreneurs starting at the earliest stages of the climb|Erica Brescia,Managing Director,Redpoint
00:00:00
Aram Mangasarian , CEO, NOXXON Pharma
00:10:00
Noel Quinn, CEO of HSBC, reviews the bank's earnings and provides an outlook for the next six months.
00:10:00
Insights from Stephen Ambrosini of 20/20 Financial Advisers
00:10:00
From Russia With Capital: DST Global's Global Tech Portfolio|John Lindfors,Cofounder And Managing Partner, DST Global
00:10:00
Renato Brunetti, President and CEO of Unidata, shares insights in an interview.